Resultados de la búsqueda 2201-2210 of 22762 for HIV/AIDS

  1. Cáncer de amígdalas - Médicos y departamentos - Mayo Clinic

    ... virus del papiloma humano (VPH) , que reducen la ... of Medicine (Biblioteca Nacional de Medicina). ... Connect with others like you for support and ...

  2. Cáncer de amígdalas - Médicos y departamentos - Mayo Clinic

    ... virus del papiloma humano (VPH) , que reducen la ... of Medicine (Biblioteca Nacional de Medicina). ... Connect with others like you for support and ...

  3. Cáncer de amígdalas - Médicos y departamentos - Mayo Clinic

    ... virus del papiloma humano (VPH) , que reducen la ... of Medicine (Biblioteca Nacional de Medicina). ... Connect with others like you for support and ...

  4. Cáncer de amígdalas - Médicos y departamentos - Mayo Clinic

    ... virus del papiloma humano (VPH) , que reducen la ... of Medicine (Biblioteca Nacional de Medicina). ... Connect with others like you for support and ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... of Q901 as monotherapy and in ... and/or positive peritoneal cytology undergoing robotic cytoreduction and hyperthermic intraperitoneal chemotherapy.

  6. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    A "Registry" is a list of basic information about people who have a certain disease or condition in common. These immune deficiency diseases are thought to be ...

  7. Mayo Clinic Obstetrics and Gynecology Physician Update - July 2022

    Page 1.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A Study to Evaluate Regional Radiotherapy in Biomarker Low-Risk Node Positive Breast Cancer. Jacksonville, Fla. The purpose of this study is to compare the ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A Study to Evaluate Regional Radiotherapy in Biomarker Low-Risk Node Positive Breast Cancer. Jacksonville, Fla. The purpose of this study is to compare the ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is for IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated ...